Predicting surgical outcome for advanced ovarian cancer, surgical standards of care, and the concept of kaizen

被引：19

作者：

Bristow, Robert E. ^{[1
]}

机构：

[1] Johns Hopkins Med Inst, Dept Oncol, Dept Gynecol & Obstet, Kelly Gynecol Oncol Serv, Baltimore, MD 21287 USA

来源：

GYNECOLOGIC ONCOLOGY | 2009年 / 112卷 / 01期

关键词：

PRIMARY PERITONEAL CANCER; IV EPITHELIAL OVARIAN; FALLOPIAN-TUBE; CYTOREDUCTION; SURVIVAL; CARCINOMA; SURGERY;

D O I：

10.1016/j.ygyno.2008.10.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1 / 3

页数：3

共 12 条

[1] Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [J].

Aletti, GD ;

Dowdy, SC ;

Gostout, BS ;

Jones, MB ;

Stanhope, CR ;

Wilson, TO ;

Podratz, KC ;

Cliby, WA .

OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :77-85

[2] Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer [J].

Axtell, Allison E. ;

Lee, Margaret H. ;

Bristow, Robert E. ;

Dowdy, Sean C. ;

Cliby, William A. ;

Raman, Steven ;

Weaver, John P. ;

Gabbay, Mojan ;

Ngo, Michael ;

Lentz, Scott ;

Cass, Ilana ;

Li, Andrew J. ;

Karlan, Beth Y. ;

Holschneider, Christine H. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (04) :384-389

[3] Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].

Bristow, RE ;

Tomacruz, RS ;

Armstrong, DK ;

Trimble, EL ;

Montz, FJ .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259

[4] A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma [J].

Chi, Dennis S. ;

Zivanovic, Oliver ;

Palayekar, Meena J. ;

Elsenhauer, Eric L. ;

Abu-Rustum, Nadeern R. ;

Sonoda, Yukio ;

Levine, Douglas A. ;

Leltao, Manio M. ;

Brown, Carol L. ;

Barakat, Richard R. .

GYNECOLOGIC ONCOLOGY, 2009, 112 (01) :6-10

[5] Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach [J].

Chi, DS ;

Franklin, CC ;

Levine, DA ;

Akselrod, F ;

Sabbatini, P ;

Jarnagin, WR ;

DeMatteo, R ;

Poynor, EA ;

Abu-Rustum, NR ;

Barakat, RR .

GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :650-654

[6] The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma [J].

Chi, DS ;

Venkatraman, ES ;

Masson, V ;

Hoskins, WJ .

GYNECOLOGIC ONCOLOGY, 2000, 77 (02) :227-231

[7] Diaphragm resection for ovarian cancer: technique and short-term complications [J].

Cliby, W ;

Dowdy, S ;

Feitoza, SS ;

Gostout, BS ;

Podratz, KC .

GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :655-660

[8] The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer [J].

Eisenhauer, Eric L. ;

Abu-Rustum, Nadeem R. ;

Sonoda, Yukio ;

Levine, Douglas A. ;

Poynor, Elizabeth A. ;

Aghajanian, Carol ;

Jarnagin, William R. ;

DeMatteo, Ronald P. ;

D'Angelica, Michael I. ;

Barakat, Richard R. ;

Chi, Dennis S. .

GYNECOLOGIC ONCOLOGY, 2006, 103 (03) :1083-1090

[9]

Griffiths C T, 1975, Natl Cancer Inst Monogr, V42, P101

[10]

May M.E., 2007, The elegant solution: Toyota's formula for mastering innovation

← 1 2 →